Within the realm of the AKT/mTOR pathway, we specifically determined that proteins involved in mRNA translational regulation were being upregulated in CLL patient samples, revealing a potential characteristic of CLL oncogenesis. The gene discussed is MTOR; the disease is B-cell chronic lymphocytic leukemia.